These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28669880)
1. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target? Patel P; Shah J J Chem Neuroanat; 2017 Nov; 85():36-42. PubMed ID: 28669880 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport. Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B; Crawford F; Bachmeier C Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326 [TBL] [Abstract][Full Text] [Related]
4. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Deane R; Sagare A; Zlokovic BV Curr Pharm Des; 2008; 14(16):1601-5. PubMed ID: 18673201 [TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice. Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749 [TBL] [Abstract][Full Text] [Related]
6. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease. Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319 [TBL] [Abstract][Full Text] [Related]
7. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Yan FL; Zheng Y; Zhao FD Acta Neuropathol; 2008 Nov; 116(5):529-35. PubMed ID: 18830615 [TBL] [Abstract][Full Text] [Related]
8. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. Deane R; Bell RD; Sagare A; Zlokovic BV CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634 [TBL] [Abstract][Full Text] [Related]
9. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Storck SE; Pietrzik CU Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494 [TBL] [Abstract][Full Text] [Related]
10. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Deane R; Zlokovic BV Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246 [TBL] [Abstract][Full Text] [Related]
12. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. Kang DE; Pietrzik CU; Baum L; Chevallier N; Merriam DE; Kounnas MZ; Wagner SL; Troncoso JC; Kawas CH; Katzman R; Koo EH J Clin Invest; 2000 Nov; 106(9):1159-66. PubMed ID: 11067868 [TBL] [Abstract][Full Text] [Related]
13. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906 [TBL] [Abstract][Full Text] [Related]
14. LRP and Alzheimer's disease. Zerbinatti CV; Bu G Rev Neurosci; 2005; 16(2):123-35. PubMed ID: 15959937 [TBL] [Abstract][Full Text] [Related]
15. Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease. Jaya Prasanthi RP; Schommer E; Thomasson S; Thompson A; Feist G; Ghribi O Mech Ageing Dev; 2008 Nov; 129(11):649-55. PubMed ID: 18845178 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways. O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019 [TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Harris-White ME; Frautschy SA Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):469-80. PubMed ID: 16266282 [TBL] [Abstract][Full Text] [Related]
19. Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype. Causevic M; Ramoz N; Haroutunian V; Davis KL; Buxbaum JD J Neuropathol Exp Neurol; 2003 Oct; 62(10):999-1005. PubMed ID: 14575236 [TBL] [Abstract][Full Text] [Related]
20. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1? Alemi M; Gaiteiro C; Ribeiro CA; Santos LM; Gomes JR; Oliveira SM; Couraud PO; Weksler B; Romero I; Saraiva MJ; Cardoso I Sci Rep; 2016 Feb; 6():20164. PubMed ID: 26837706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]